333 related articles for article (PubMed ID: 25119341)
1. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.
Monjazeb AM; Tietze JK; Grossenbacher SK; Hsiao HH; Zamora AE; Mirsoian A; Koehn B; Blazar BR; Weiss JM; Wiltrout RH; Sckisel GD; Murphy WJ
PLoS One; 2014; 9(8):e102709. PubMed ID: 25119341
[TBL] [Abstract][Full Text] [Related]
2. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.
Sckisel GD; Tietze JK; Zamora AE; Hsiao HH; Priest SO; Wilkins DE; Lanier LL; Blazar BR; Baumgarth N; Murphy WJ
Clin Exp Immunol; 2014 Jan; 175(1):79-91. PubMed ID: 23937663
[TBL] [Abstract][Full Text] [Related]
3. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion.
Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS
Front Immunol; 2020; 11():7. PubMed ID: 32117218
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
Jackaman C; Nelson DJ
Cancer Immunol Immunother; 2012 Apr; 61(4):549-60. PubMed ID: 22002241
[TBL] [Abstract][Full Text] [Related]
5. Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1.
Fuse S; Tsai CY; Molloy MJ; Allie SR; Zhang W; Yagita H; Usherwood EJ
J Immunol; 2009 Apr; 182(7):4244-54. PubMed ID: 19299723
[TBL] [Abstract][Full Text] [Related]
6. Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60.
Ryu SJ; Jung KM; Yoo HS; Kim TW; Kim S; Chang J; Choi EY
Blood; 2009 Apr; 113(18):4273-80. PubMed ID: 19139082
[TBL] [Abstract][Full Text] [Related]
7. Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy.
Sckisel GD; Mirsoian A; Bouchlaka MN; Tietze JK; Chen M; Blazar BR; Murphy WJ
Cancer Immunol Immunother; 2015 Dec; 64(12):1541-52. PubMed ID: 26423422
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.
Butler MO; Imataki O; Yamashita Y; Tanaka M; Ansén S; Berezovskaya A; Metzler G; Milstein MI; Mooney MM; Murray AP; Mano H; Nadler LM; Hirano N
PLoS One; 2012; 7(1):e30229. PubMed ID: 22279573
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
10. CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.
Sokke Umeshappa C; Hebbandi Nanjundappa R; Xie Y; Freywald A; Deng Y; Ma H; Xiang J
PLoS One; 2012; 7(10):e47004. PubMed ID: 23071696
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligation in vivo induces bystander proliferation of memory phenotype CD8 T cells.
Koschella M; Voehringer D; Pircher H
J Immunol; 2004 Apr; 172(8):4804-11. PubMed ID: 15067057
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis.
Phares TW; Stohlman SA; Hinton DR; Bergmann CC
J Neuroinflammation; 2012 Dec; 9():269. PubMed ID: 23237504
[TBL] [Abstract][Full Text] [Related]
13. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
14. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
Croft M; Carter L; Swain SL; Dutton RW
J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
[TBL] [Abstract][Full Text] [Related]
15. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy.
Sckisel GD; Mirsoian A; Minnar CM; Crittenden M; Curti B; Chen JQ; Blazar BR; Borowsky AD; Monjazeb AM; Murphy WJ
J Immunother Cancer; 2017; 5():33. PubMed ID: 28428882
[TBL] [Abstract][Full Text] [Related]
16. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
Niedbala W; Wei X; Liew FY
Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
[TBL] [Abstract][Full Text] [Related]
17. Bystander activation of CD4+ T cells.
Boyman O
Eur J Immunol; 2010 Apr; 40(4):936-9. PubMed ID: 20309907
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.
Aubert RD; Kamphorst AO; Sarkar S; Vezys V; Ha SJ; Barber DL; Ye L; Sharpe AH; Freeman GJ; Ahmed R
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21182-7. PubMed ID: 22160724
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
[TBL] [Abstract][Full Text] [Related]
20. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.
Narayan S; Kolly L; So A; Busso N
Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
